RT Journal Article
SR Electronic
T1 Environmental indicator for effective control of COVID-19 spreading
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.12.20099804
DO 10.1101/2020.05.12.20099804
A1 Lian, Xinbo
A1 Huang, Jianping
A1 Zhang, Li
A1 Liu, Chuwei
A1 Liu, Xiaoyue
A1 Wang, Lina
YR 2020
UL http://medrxiv.org/content/early/2020/07/27/2020.05.12.20099804.abstract
AB Recently, a novel coronavirus (COVID-19) has caused viral pneumonia worldwide, spreading to more than 200 countries, posing a major threat to international health. To prevent the spread of COVID-19, in this study, we report that the city lockdown measure was an effective way to reduce the number of new cases, and the nitrogen dioxide (NO2) concentration can be adopted as an environmental lockdown indicator. In China, after strict city lockdown, the average NO2 concentration decreased 55.7% (95% confidence interval (CI): 51.5-59.6%) and the total number of newly confirmed cases decreased significantly. Our results also indicate that the global airborne NO2 concentration steeply decreased over the vast majority of COVID-19-hit areas based on satellite measurements. We found that the total number of newly confirmed cases reached an inflection point about two weeks after the lockdown. The total number of newly confirmed cases can be reduced by about 50% within 30 days of the lockdown. The stricter lockdown will help newly confirmed cases to decline earlier and more rapidly. Italy, Germany and France are good examples. Our results suggest that NO2 satellite measurement can help decision makers effectively monitor control regulations to reduce the spread of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was jointly supported by the National Science Foundation of China (41521004) and the Gansu Provincial Special Fund Project for Guiding Scientific and Technological Innovation and Development (Grant No. 2019ZX-06).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No patients are involved in this article.This article complies with all relevant ethical guidelines.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used during the study were provided by a third party. (List items). Direct requests for these materials may be made to the provider. https://disc.gsfc.nasa.gov/datasets/OMNO2d_003 http://www.cnemc.cn/. https://github.com/CSSEGISandData/COVID-19